TrialBritish journal of clinical pharmacology2022

Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model-based approach.

Philippe Jacqmin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.